Form 4 filings across 3 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$1.8M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 6 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 24 most recent Form 4 transactions.
| RPRX |
| Royalty Pharma plc |
| AGRANT |
| 815 |
| $45.98 |
| $37.5K |
| +1.1% |
| Open the original filing on SEC.gov |
| Jan 7 | CDTX | Cidara Therapeutics, Inc. | DTOISS◆ | 11,100 | — | — | — | Open the original filing on SEC.gov |
| Jan 7 | CDTX | Cidara Therapeutics, Inc. | DTOISS◆ | 16,000 | — | — | — | Open the original filing on SEC.gov |
| Jan 7 | CDTX | Cidara Therapeutics, Inc. | DTOISS◆ | 2,125 | — | — | — | Open the original filing on SEC.gov |
| Jan 7 | CDTX | Cidara Therapeutics, Inc. | DTOISS◆ | 2,125 | — | — | — | Open the original filing on SEC.gov |
| Jan 7 | CDTX | Cidara Therapeutics, Inc. | DTOISS◆ | 1,400 | — | — | — | Open the original filing on SEC.gov |
| Jan 7 | CDTX | Cidara Therapeutics, Inc. | DTOISS◆ | 875 | — | — | — | Open the original filing on SEC.gov |
| Jan 7 | CDTX | Cidara Therapeutics, Inc. | DTOISS◆ | 1,750 | — | — | — | Open the original filing on SEC.gov |
| Jan 7 | CDTX | Cidara Therapeutics, Inc. | DTOISS | 15 | $221.50 | $3.3K | -100.0% | Open the original filing on SEC.gov |
| Jan 7 | REGN | Regeneron Pharmaceuticals,… | MEXER◷◆ | 1,500 | — | — | — | Open the original filing on SEC.gov |
| Jan 7 | REGN | Regeneron Pharmaceuticals,… | SSELL◷ | 1,500 | $800.00 | $1.2M | -46.8% | Open the original filing on SEC.gov |
| Jan 7 | REGN | Regeneron Pharmaceuticals,… | MEXER◷ | 1,500 | $374.12 | $561.2K | +88.1% | Open the original filing on SEC.gov |
| Jan 2 | REGN | Regeneron Pharmaceuticals,… | AGRANT◆ | 1,962 | — | — | — | Open the original filing on SEC.gov |
| Jan 2 | REGN | Regeneron Pharmaceuticals,… | AGRANT | 155 | — | — | +10.0% | Open the original filing on SEC.gov |
| Dec 31, 2025 | RPRX | Royalty Pharma plc | AGRANT | 967 | $38.74 | $37.5K | +1.3% | Open the original filing on SEC.gov |
| Nov 20, 2025 | REGN | Regeneron Pharmaceuticals,… | MEXER◷◆ | 760 | — | — | — | Open the original filing on SEC.gov |
| Nov 20, 2025 | REGN | Regeneron Pharmaceuticals,… | SSELL◷ | 760 | $750.00 | $570K | -32.9% | Open the original filing on SEC.gov |
| Nov 20, 2025 | REGN | Regeneron Pharmaceuticals,… | MEXER◷ | 760 | $371.40 | $282.3K | +49.1% | Open the original filing on SEC.gov |
| Sep 30, 2025 | RPRX | Royalty Pharma plc | AGRANT | 1,047 | $35.79 | $37.5K | +1.5% | Open the original filing on SEC.gov |
| Jun 30, 2025 | RPRX | Royalty Pharma plc | AGRANT | 1,064 | $35.24 | $37.5K | +1.5% | Open the original filing on SEC.gov |
| Jun 18, 2025 | CDTX | Cidara Therapeutics, Inc. | AGRANT◆ | 11,100 | — | — | — | Open the original filing on SEC.gov |
| May 13, 2025 | RPRX | Royalty Pharma plc | AGRANT | 7,614 | — | — | +12.2% | Open the original filing on SEC.gov |